4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-23-000125
Chief Medical Officer sold 2,768 shares at $23.79 ($65,851)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Carole Chief Medical Officer | 2023-08-14 | Sale 10b5-1 | −2,768 | $23.79 | $65,851 | 182,809 | I: show line 1 in the form |
| Open-market sales · 2,768 sh · avg $23.79 · $65,851 | |||||||
Loading xslF345X05/wk-form4_1692224392.xml…